Trinity Gold Nutrition — Class II drug recall D-0042-2025
Ongoing recall by Trinity Gold Nutrition, reported 2024-11-20, distributed nationwide. Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen,
| Recall number | D-0042-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Trinity Gold Nutrition, Fort Mill, SC, United States |
| Recall initiated | 2024-11-06 |
| Classified | 2024-11-12 |
| Reported by FDA | 2024-11-20 |
| Distributed | Nationwide (US) |
| Countries outside the US | AU, CA, GB |
| Quantity | 150 |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00802992001009 |
| Lot numbers | IN-030 |
| Expiration dates | 2027-11-20 |
Product
Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPC 802992001009
Reason for recall
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0042-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.